Photosensitivity clinical trials

Explore recruiting photosensitivity clinical trials.

Recruiting photosensitivity studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Photosensitivity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase III, randomized, double blind, multiple doses, placebo-controlled parallel-group, adaptive study to evaluate the efficacy of atropine to treat the progression of myopia in children and adolescents from 3 to less than 18 years of age (MODERATO Study)

Poland, Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Multicenter, Randomized, Double-blind Study of Safety and Efficacy of EL219 versus Standard of Care (Liposomal Amphotericin B followed by Voriconazole) for Early Antifungal Therapy of Suspected Invasive Mould Infections

Belgium, France, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene

Netherlands, Germany, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene

France, Belgium, Netherlands, Germany, Denmark, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Photosensitivity trials by city

Photosensitivity in Toronto Photosensitivity in Vancouver Photosensitivity in Montreal Photosensitivity in Calgary Photosensitivity in Edmonton Photosensitivity in Ottawa Photosensitivity in Winnipeg Photosensitivity in Quebec City Photosensitivity in Hamilton Photosensitivity in Kitchener Photosensitivity in London Photosensitivity in Halifax Photosensitivity in New York Photosensitivity in Los Angeles Photosensitivity in Chicago Photosensitivity in Houston

Photosensitivity clinical trials

Recruiting photosensitivity studies right now

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP

Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects

Cannabis Effects on Sleep, Circadian Rhythms, and Light Sensitivity in Young Adults

Pilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain Injury

Undergraduate Skin Cancer Prevention Trial

Also recruiting in Europe

A phase III, randomized, double blind, multiple doses, placebo-controlled parallel-group, adaptive study to evaluate the efficacy of atropine to treat the progression of myopia in children and adolescents from 3 to less than 18 years of age (MODERATO Study)

A Phase 2, Multicenter, Randomized, Double-blind Study of Safety and Efficacy of EL219 versus Standard of Care (Liposomal Amphotericin B followed by Voriconazole) for Early Antifungal Therapy of Suspected Invasive Mould Infections

A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene

A Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene

Photosensitivity trials by city

Other conditions